Key facts
- The DEA permitted hundreds of thousands of fentanyl pills to be distributed in New Mexico.
- This tactic was reportedly used to build federal prosecutions.
- Whistleblower David Howell claims the DEA gambled with public safety.
- Fentanyl's potency and lethality make the 'walk' drug tactic particularly problematic.
- Agents monitored a shipment of an estimated 74,000 pills in Albuquerque.
- The DEA defended its actions, stating investigative decisions were lawful and consistent with guidance.
An Associated Press investigation, co-written by reporters Jim Mustian and Joshua Goodman, has revealed that the U.S. Drug Enforcement Administration (DEA) allowed hundreds of thousands of fentanyl pills to be distributed in New Mexico. This controversial tactic was reportedly employed to gather intelligence for larger federal prosecutions.